Anti-KDM3B/ 5qNCA/ C5orf7 functional antibody
Anti-KDM3B/ 5qNCA/ C5orf7 functional antibody for cell culture, ELISA & in-vivo assay
 Go to KDM3B/KDM3B products collection >>
Go to KDM3B/KDM3B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc) 
Product information
| Catalog No. | Product Name | Species Reactivity | 
|---|---|---|
| GM-Tg-hg-SE1480-Ab-1/ GM-Tg-hg-SE1480-Ab-2 | Anti-Human KDM3B monoclonal antibody | Human | 
| GM-Tg-rg-SE1480-Ab-1/ GM-Tg-rg-SE1480-Ab-2 | Anti-Rat KDM3B monoclonal antibody | Rat | 
| GM-Tg-mg-SE1480-Ab-1/ GM-Tg-mg-SE1480-Ab-2 | Anti-Mouse KDM3B monoclonal antibody | Mouse | 
| GM-Tg-cynog-SE1480-Ab-1/ GM-Tg-cynog-SE1480-Ab-2 | Anti-Cynomolgus/ Rhesus macaque KDM3B monoclonal antibody | Cynomolgus/ Rhesus macaque | 
| GM-Tg-felg-SE1480-Ab-1/ GM-Tg-felg-SE1480-Ab-2 | Anti-Feline KDM3B monoclonal antibody | Feline | 
| GM-Tg-cang-SE1480-Ab-1/ GM-Tg-cang-SE1480-Ab-2 | Anti-Canine KDM3B monoclonal antibody | Canine | 
| GM-Tg-bovg-SE1480-Ab-1/ GM-Tg-bovg-SE1480-Ab-2 | Anti-Bovine KDM3B monoclonal antibody | Bovine | 
| GM-Tg-equg-SE1480-Ab-1/ GM-Tg-equg-SE1480-Ab-2 | Anti-Equine KDM3B monoclonal antibody | Equine | 
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. | GM-Tg-hg-SE1480-Ab-1/ GM-Tg-hg-SE1480-Ab-2; GM-Tg-rg-SE1480-Ab-1/ GM-Tg-rg-SE1480-Ab-2; GM-Tg-mg-SE1480-Ab-1/ GM-Tg-mg-SE1480-Ab-2; GM-Tg-cynog-SE1480-Ab-1/ GM-Tg-cynog-SE1480-Ab-2; GM-Tg-felg-SE1480-Ab-1/ GM-Tg-felg-SE1480-Ab-2; GM-Tg-cang-SE1480-Ab-1/ GM-Tg-cang-SE1480-Ab-2; GM-Tg-bovg-SE1480-Ab-1/ GM-Tg-bovg-SE1480-Ab-2; GM-Tg-equg-SE1480-Ab-1/ GM-Tg-equg-SE1480-Ab-2 | 
| Products Name | Anti-KDM3B monoclonal antibody | 
| Format | mab | 
| Target Name | KDM3B | 
| Protein Sub-location | Secreted Protein/Potential Cytokines | 
| Category of antibody | FACS/Biofunctional Antibody | 
| Derivation (species) | Mouse | 
| CH1+2+3 Isotype (Receptor identification) | IgG | 
| Type of Light Chain (VD-LC) | N/A | 
| Expression platform | Mammalian Expression | 
| Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). | 
| Tag | Fc | 
| Products description | Pre-made anti-KDM3B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) | 
| Purity | Purity: ≥95% (SDS-PAGE) | 
| Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. | 
| Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. | 
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. | 
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name | 
| Target Antigen | GM-Tg-g-SE1480-Ag-1 | Recombinant multi-species KDM3B/ 5qNCA/ C5orf7 protein | 
Target information
| Target ID | GM-SE1480 | 
| Target Name | KDM3B | 
| Gene ID | 51780,277250,682469,716648,474695,101087899,100848816,100062288 | 
| Gene Symbol and Synonyms | 5830462I21Rik,5qNCA,C5orf7,DIJOS,JHDM2B,JMJD1B,KDM3B,mKIAA1082,NET22 | 
| Uniprot Accession | Q7LBC6 | 
| Uniprot Entry Name | KDM3B_HUMAN | 
| Protein Sub-location | Secreted Protein/Potential Cytokines | 
| Category | |
| Disease | N/A | 
| Gene Ensembl | ENSG00000120733 | 
| Target Classification | N/A | 
The target: KDM3B, gene name: KDM3B, also named as 5qNCA, C5orf7, JMJD1B, NET22. Predicted to enable chromatin DNA binding activity; histone H3-methyl-lysine-9 demethylase activity; and transcription coregulator activity. Predicted to be involved in histone H3-K9 demethylation and regulation of transcription by RNA polymerase II. Located in nucleoplasm. Biomarker of acute lymphoblastic leukemia; breast cancer; colorectal cancer; and lung non-small cell carcinoma. [provided by Alliance of Genome Resources, Apr 2022].
About Gmab


GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.
 
                
                 
             
         
        

 MSDS
MSDS